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ABSTRACT
Staphylococcus aureus displays a clonal population
structure in which horizontal gene transfer between
different lineages is extremely rare. This is due, in
part, to the presence of a Type I DNA restriction–
modification (RM) system given the generic name of
Sau1, which maintains different patterns of methyla-
tion on specific target sequences on the genomes
of different lineages. We have determined the tar-
get sequences recognized by the Sau1 Type I RM
systems present in a wide range of the most preva-
lent S. aureus lineages and assigned the sequences
recognized to particular target recognition domains
within the RM enzymes. We used a range of biochem-
ical assays on purified enzymes and single molecule
real-time sequencing on genomic DNA to determine
these target sequences and their patterns of methy-
lation. Knowledge of the main target sequences for
Sau1 will facilitate the synthesis of new vectors for
transformation of the most prevalent lineages of this
‘untransformable’ bacterium.
INTRODUCTION
Type I DNA restriction–modification (RM) systems are
found in about half of the sequenced prokaryotic genomes
(1–4). They present a formidable barrier to the invasion
of the host cell by foreign DNA whether by transduction,
transformation or conjugation and thus exercise control
over horizontal gene transfer (HGT) (1,4–8). As an exam-
ple of their effectiveness, less than 1 in 104 or 105 phage in-
fections can successfully avoid the classical EcoKI Type I
RM system of Escherichia coliK12. In some circumstances,
such as when anti-restriction systems are absent (9), when
there aremultiple target sites on the phage (10) or whenRM
expression is raised (11), the barrier due to this single RM
system can be even greater. RM systems operate by methy-
lating defined target sequences on the host genome and they
maintain this methylation pattern through each round of
DNA replication (modification). ForeignDNA entering the
cell often contains the same target sequence but in an un-
methylated state. These unmethylated target sequences are
targeted for endonucleolytic cleavage by the RM system (re-
striction). The Type I RM system comprises three hsd (host
specificity forDNA) genes, hsdR, hsdM and hsdS for restric-
tion, modification and target sequence specificity respec-
tively. The gene products form anR2M2S1 complex inwhich
HsdS (or S) recognizes the target sequence, HsdM (or M)
recognizes the methylation status of the target and methy-
lates hemimethylated targets while HsdR (or R) cleaves the
DNA containing unmethylated targets after a complex re-
action involving adenosine triphosphate (ATP) hydrolysis
and DNA translocation (12). An M2S1 complex can act
solely as a methyltransferase (MTase) (13). Type I RM en-
zymes almost always recognize and methylate adenine nu-
cleotides in their target sequences to form N6-methyl ade-
nine (6mA) although a few forming N4-methyl cytosine
(m4C) are now known (3,14). In addition to the protection
offered by Type I, II and III RM systems, Type IV restric-
tion systems can attack foreignDNAcontainingmethylated
sequences not found in the host (15).
The presence of multiple RM systems in a single host
can increase the barrier to HGT still further. For instance,
Staphylococcus aureus often contains two related Type I
RM systems making its transformation extremely ineffi-
cient and hindering the genetic analysis of this organism
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(16–19). These genomes contain two hsdM and two hsdS
and share a single hsdR, although some S. aureus strains
have different numbers of hsdM and hsdS (Figure 1A). The
presence of only a single hsdR is not a problem as it can
interact with each hsdMhsdS pair. It has long been known
that S. aureus displays a clonal population structure (20) in
which HGT between different clonal complexes is exceed-
ingly rare. Multilocus sequence typing, microarray analysis
and whole genome sequencing divides lineages of S. aureus
and close relatives into the clonal complexes (CC) (20–23),
each of which carries a different range of mobile genetic el-
ements and antibiotic resistance genes on the genome (24–
27). Each CC can be further subdivided into sequence types
(ST) (22). Waldron and Lindsay (16) first realized that each
CC of S. aureus contained a unique pair of Type I RM
systems. A Type IV restriction system, SauUSI, was also
identified later and recognized as a methyl-dependent re-
striction enzyme which would prevent the uptake of foreign
DNA containing C5-methyl cytosine (5mC) (28,29). Thus
most genetic manipulation of S. aureus is confined to strain
RN4220, which has a defective Type I RM system due to a
premature stop codon in hsdR. Furthermore, to avoid the
Type IV system, DNA needs to be prepared from an E. coli
strain, such asE. coliER2796, lacking theDcm5mCMTase
(30).
The Type I RM systems in different strains of S. au-
reus were given the informal name of Sau1 by Waldron and
Lindsay (16) and it is clear from not only a comparison
of the sequences of genes and proteins but also from the
ability to use subunits from one strain to complement sub-
units from other strains (31) that the term Sau1 describes a
classical ‘family’ of Type I RM systems. Type I RM fami-
lies, Type IA to Type IE, were originally defined in E. coli
and Salmonella enterica by DNA hybridization, antibody
cross reactivity and subunit complementation (32,33), al-
though now it is more usual to use the high levels of se-
quence identity (over 90%) in HsdM and HsdR to define
a family in silico. Although the name Sau1 for this family
of Type I RM systems in S. aureus is an informal one not
following the usual conventions (34), we retain it as it is es-
tablished in the literature. However, it is important to note
that some strains of S. aureus show additional Type I RM
systems, which show limited amino acid sequence identity
to the HsdR, HsdM and HsdS of Sau1 (Figure 1A). For
instance, Monk et al. (35) identified an active Type I RM
system, SauJKDIII, in S. aureus JKD6159 which showed
low sequence identity to members of the Sau1 family. This
is clearly a member of a new and different Type I RM fam-
ily whose subunits will be unable to interact with the Sau1
HsdM and HsdR (D. T. F. Dryden, J. A. Lindsay andM. T.
G. Holden, in preparation).
The Sau1 Type I RM systems are so effective because
they show great variability in the target sequences recog-
nized thus preventing HGT between CC but allowing HGT
between strains within a CC (31,35,36). This variability in
target sequences is due to the modular construction of the
Type I RM systems (Figure 1B). The S subunit contains two
target recognition domains (TRDs) each of which recog-
nizes one half of a bipartite target, for example the first Type
I RM system in CC1, given the generic name CC1-1, rec-
ognizes CCAYNNNNNTTAA (adenine methylation sites
Figure 1. Staphylococcus aureus genomes showing the genes and the typ-
ical organization of target recognition domains (TRDs) in the HsdS
DNA sequence specificity subunit. (A) Strain ED133 (CC133) has two
hsdS; strain 11819–97 (CC80) has three hsdS (CC80) and strain JKD6159
(CC93) contains an extra Type I RM system from a different Type I RM
family. From top to bottom: ED133, 11819–97, JKD6159. hsdR (red),
hsdM (blue), hsdS (yellow). (B) The structural organization of the HsdS
specificity subunit. The conserved regions (cr) are common to all S sub-
units within a family. The two TRDs (TRD1 and TRD2) define the target
sequences recognized by the RM enzyme and can be swapped between S
subunits of the same family to generate new specificities.
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are underlined) (35,36). Swapping TRDs between S sub-
units generates new targets, for example the second Type
I RM enzyme in CC1, termed CC1-2, couples the first
TRD of CC1-1 with a different second TRD to recognize
CCAYNNNNNNTGT. This swapping is easy because the
DNA for S subunits contain conserved sequences bound-
ing each TRD. Most S. aureus strains have two copies of
hsdS, two of hsdM and one of hsdR. Thus, there are often
four TRDs in each CC, which define the restriction bar-
rier against HGT. Some Type I RM enzymes have half-size
HsdS incorporating only a single TRD. It has been shown
that these products are often able to dimerize and recog-
nize symmetric target sequences (37–39). We have been able
to recapitulate these results on ‘half-HsdS’ enzymes by ma-
nipulating the CC398-1 S. aureus system (E. K. M. Bower
and D. T. F. Dryden, unpublished results).
Previously we have identified the target sequences recog-
nized by several common community-associated, hospital-
associated and livestock-associated MRSA clonal com-
plexes (31,36) and recently several more have been identified
(3,35,40). Monk et al. (35) and Jones et al. (40) have used
this information to prepare DNAmethylated by the MTase
M2S1 component enzymes to aid the transformation of S.
aureus strains that are usually resistant to transformation.
The identification of further targets recognized by the S
subunits of Sau1 Type I RM systems would in principle al-
low more CC to be transformed for genetic analysis. In ad-
dition, further understanding of the structural requirements
for TRDs to recognize different specific DNA sequences
is of intense interest as the Type I RM systems are very
widespread in bacteria and archaea (1,4) and exert a consid-
erable pressure on HGT and the evolution of prokaryotes.
For instance, the use of multiple TRDs being exchanged be-
tween strains has been observed in Helicobacter (41), My-
coplasma (42,43), Streptococci (44,45) and Bacteroides (46).
Here we identifymany further TRDs and their targets us-
ing both biochemical and PacBio single-molecule real-time
(SMRT) sequencing methods to define the barriers to HGT
in a wide range of S. aureus CC of global importance.
MATERIALS AND METHODS
Nomenclature for expression plasmids encoding newMTases
As each Type I S subunit contains two TRDs and we pro-
pose to determine the targets recognized by each TRD, we
have given each TRD a single letter code, Table 1, and refer
to the plasmids as pSauTRD1-TRD2, e.g. pSauBI expresses
an S subunit containing TRD B and TRD I and theM sub-
unit. If the TRD combination is the same as that found in a
known clonal complex, then that CC is also given in brack-
ets. The MTase would be called M.SauBI in this example
and the S subunit S.SauBI and is from CC22. All sequences
are given in the Supplementary Data.
Preparation of M.SauBI (CC22-1), M.SauCD (CC30-1),
M.SauJK (CC30-2) and M.SauCL (CC45-1)
These fourMTases were prepared as EGFP-His tag fusions
as described in Roberts et al. (31). pSauBI-EGFP (CC22-1,
genomic DNA fromMRSA5906), pSauCD-EGFP (CC30-
1, genomic DNA fromMRSA252), pSauJK-EGFP (CC30-
Table 1. TRD targets shown from 5′ to 3′
The underlined A indicates the site of adenine methylation. TRD pair B
and P, and TRD pair U and c* recognize the same DNA sequence and are
highlighted in red. In the targets, Y = C or T; R = A or G; W = A or T;
H = A, T or C; N = A, G, T or C.
2, genomic DNA from MRSA252) and pSauCL-EGFP
(CC45-1, genomic DNA from strain 70642) were all con-
structed by the polymerase chain reaction (PCR) with their
hsdS fused to DNA encoding EGFP and a His-tag, with
the following locus-specific oligonucleotides priming from
the 3′ end of the genes encoding the S subunits:
CC22-1 BI BS 5′GATCGAATTCCGGATCCAATAA
ACATCTTTTGTAAAAACAC3′
CC30-1 CD BS 5′GATCGAATTCCGGATCCTAAGA
ACATCTTTTGTAAAAAGG3′
CC30-2 JK BS 5′GATCGAATTCCGGATCCTATAA
AAATTTTTTGAAGTAATCCTTG3′
CC45-1 CLR167KBS 5′GATCGAATTCCGGATCCA
ATAAACATCGATTTAAGTAAGGC3′
The sequence for CC45-1 introduced a single mutation
R167K in the first TRD in the S subunit but since this
change is found in other S. aureus isolates containing this
TRD, the change is presumed to be completely neutral.
A new vector for MTase expression: pJF118his
Although we had not experienced problems in examining
the fusion proteins of S subunits and EGFP in biochem-
ical work, we decided to construct a vector encoding hsdS
with only a C-terminal His-tag. Vector pJF118his wasmade
by PCR of the plasmid encoding the MTase CC5-1-EGFP
constructed in Roberts et al. (31) with these two oligonu-
cleotides:
pJFMShisTS 5′AGCTTCGAGAGGATCCCATCAT
CATCATCATCATTAAGAATTCAGCTTGGCTGTTT
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TGGCGG3′ and pJFMSEGFPhisBS 5′GAGTGAATCC
CCGGGGATCCGTCGACC3′.
The resulting PCR product was cut with BamHI and
unimolecular religation gave pJF118his into which the hs-
dMS operon could be ligated as BamHI fragments and from
which all subsequent MTase clones were descended.
Construction of an MTase plasmid to allow TRD swaps:
pSaudeltaXmaI
A PCR-based strategy was devised to allow free pairwise
assortment of desired TRDs in HsdS. Many, but not all
of the HsdS subunits, including that encoded by the Type
I system in CC398 (36), have a predicted proline-glycine
sequence near the N-terminus. This dipeptide can be en-
coded by CCCGGG, which would be a target site for SmaI
or XmaI. Oligonucleotides were designed which would
introduce this motif in the N-terminus (a replacement
with no amino acid changes) and at the C terminus (an
insertion of two amino acids) of the S subunit of the CC398
system (36), by a two stage PCR fusion. Thus, primary
PCR products were generated by reactions primed by:
PromoterJF 5′GCTTCTGGCGTCAGGCAGCC3′ with
398SmaIOligoBS 5′CCCATTCGCCTTCAAACCCG
GGGAATCTCAACTCTGGCAC3′ and 398SmaIOlig-
oTS 5′GTGCCAGAGTTGAGATTCCCCGGGTT
TGAAGGCGAATGGG3′ with 398SmaIBamHI
5′GATCGATCGGATCCCCCGGGAATAAACATC
TTTTGAAGTAATGAC3′.
The purified PCR products were then fused in a
secondary PCR reaction primed by PromoterJF with
398SmaIBamHI. The product was then cut with BamHI,
and ligated into the BamHI site of pJF118his as pSauNE-
XmaI. This mutated form of the CC398-1MTase, could as-
semble the complete restriction enzyme that proved to be
active in endonucleolytic cleavage (36). This indicated that
insertion of a proline and glycine toward the C-terminus did
not affect the function of the enzyme. Subsequently, on re-
analyzing the DNA sequence, a single PCR mutation was
discovered within the XmaI fragment. This caused a mu-
tation A50S but this clearly did not affect the specificity
or function of the S subunit in our assays. Digestion of
pSauNE-XmaI with XmaI followed by intramolecular re-
ligation of the vector fragment generates pSaudeltaXmaI,
into which any pairwise combination of TRDS with XmaI
cohesive ends may be inserted.
Construction of MTases M.SauNI, M.SauND, M.SauNK,
M.SauNL, M.SauBE, M.SauJE and M.SauCE (ST425-1)
containing hybrid S subunits
The DNA for each TRD of these S subunits was fused
to the DNA for the reciprocal TRD of S.SauNE
(CC398-1). This was achieved by creating primary
PCRs with a short area of homology, which then al-
lowed base pairing of single strands of each PCR, in
a secondary PCR. For example, S.SauBE TRD B was
generated from an appropriate plasmid template by
PCR with oligonucleotides, TRD1FOR398SmaIOligoTS
5′GTGCCAGAGTTGAGATTCCCCGGGTTTGAA
GGCGAATGGG3′ paired with TRD1nearuniversal
5′GTTCTTCTAATTCAATTTGT3′. TRD E was
similarly generated by PCR from plasmid template
with oligonucleotides TRD2nearuniversal 5′ACAA
ATTGAATTAGAAGAAC3′ and 398SmaIBamHI
5′GATCGATCGGATCCCCCGGGAATAAACATC
TTTTGAAGTAATGAC3′. The final insert was then
generated by PCR with the two gel-purified primary
oligonucleotides and TRD1FOR398SmaIOligoTS
5′GTGCCAGAGTTGAGATTCCCCGGGTT
TGAAGGCGAATGGG3′ and 398SmaIBamHI
5′GATCGATCGGATCCCCCGGGAATAAACATC
TTTTGAAGTAATGAC3′. S.SauCL was the only sub-
unit for which we could not use the central universal
oligonucleotides for PCR and required specific substitutes:
TRDLFOR/CC45-1 5′ACAAATTGAATTAGAAGA
ACAAAAACTTGAATTACTTCAACAACAG3′ and
TRDC/CC45-1 5′GTTCTTCTAATTCAATTTGTCG
ATCGAGTTTGCTGAAGAAG3′. Each C-terminus is
unique andwhere TRD2was not TRDE, a specific oligonu-
cleotide was employed: TRDIREV/CC22-1c-termsmaI
5′GATCGATCGGATCCCCCGGGAATAAACATCTT
TTGTAAAAACAC3′, TRDDREV/CC30-1c-termsmaI
5′GATCGATCGGATCCCCCGGGTAAGAACATC
TTTTGTAAAAAGGATTG3′, TRDKREV/CC30-
2c-termsmaI 5′GATCGATCGGATCCCCCGGG
TATAAAAATTTTTTGAAGTAATCCTTG3′ and
TRDLREV/CC45-1c-termsmaI 5′GATCGATCGGAT
CCCCCGGGAATAAACATCGATTTAAGTAAGGC3′.
Each pure secondary PCR product was cut with XmaI and
ligated into the XmaI site of pSaudeltaXmaI.
Construction of further MTases with further combinations of
TRDs using synthetic genes
Additional hsdS sequences were obtained as synthetic genes
from GeneArt (ThermoFisher Scientific) with sequences
optimized for expression in E. coli (Supplementary Data).
All the first TRDs begin with 5′CCCGGGTTTGAAGG
CGAATGGGAG3′, except that for CC80-2 which begins
with 5′CCCGGGTTTGAAGGCGAATATTCT3′. All the
first TRDs end with 5′CAAATTGAATTAGAAGAACA
GAAG3′. All the second TRDs begin with 3′CAAATTGA
ATTAGAAGAACAGAAG5′ and have a universal reverse
oligonucleotide, Trd2unirev 5′GATCGATCGGATCCCC
CGGG3′. These conserved sequences were used to create
oligonucleotides to prime PCR reactions. Each pure sec-
ondary PCR product was cut with XmaI and ligated into
the XmaI site of pSaudeltaXmaI. The orientation of the
fragments was determined by PCR.
Expression and purification of MTases
These new MTases and the R subunit of CC5 were ex-
pressed in E. coli BL21(DE3) and purified via HisTrap
chromatography, size exclusion chromatography, diethy-
laminoethyl anion exchange chromatography and, if nec-
essary, Heparin HiTrap chromatography (GE Healthcare,
Uppsala, Sweden) as described previously (31).
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Nuclease and ATPase assays
Purified MTases were mixed with the CC5 R subunit and
used in assays for ATP hydrolysis (ATPase) activity (cou-
pled enzyme assay following a change in absorbance of
NADH) and DNA cleavage activity (plasmid cutting assay
with analysis via agarose gel electrophoresis) as previously
described (31,36).
Preparation of genomic DNA for SMRT sequencing
The expression plasmids harboring the various MTases
were used to transform a non-methylating (dam− dcm−)
strain ofE. coliER2796 (30). Single colonies from the trans-
formation plate of Lysogeny Broth (LB) agar medium sup-
plementedwith 10g/ml kanamycin, 10g/ml tetracycline
as well as 100 g/ml carbenicillin, which acted as a selec-
tion marker for the expression construct, were picked and
used to inoculate 5 ml of LB containing the same cocktail
of antibiotics. The cultures were incubated overnight with
shaking at 37◦C and 1 ml aliquots of the overnight culture
were then pelleted by centrifugation (6000 g, 6 min, 4◦C).
The culture medium was carefully removed and the cell pel-
lets stored at −20◦C until required. Genomic DNA was
prepared from each cell pellet using the Wizard Genomic
DNA purification kit (Promega, Madison, WI, USA) ac-
cording to the manufacturer’s instructions. The quality of
the genomic DNA preparations was initially assessed by
agarose gel electrophoresis and from the shape of the ab-
sorbance profile from 240 to 340 nm. Genomic DNA from
S. aureus strains LGA251 (a kind gift from Mark Holmes)
and NCTC13435 (a kind gift fromAngela Kearns) was pre-
pared by using the PurElut Bacterial Genomic Kit (Edge-
Bio, Gaithersburg, MD 20877, USA). The DNA library for
SMRT sequencingwas prepared and subsequently analyzed
as described in Anton et al. (30).
Methylation of plasmids using M.EcoGII
M.EcoGII was kindly supplied by Dr Iain Murray (New
England Biolabs) and used tomodify plasmids E2, E5, E10,
E11 and E12 previously described (31) and plasmid pCN36
(47). A total of 0.45 g DNA was methylated using 2.0 U
of M.EcoGII for 100 min at 37◦C in a 50 l volume. The
reaction was in 1×NEB4 buffer (50 mM potassium acetate,
20 mM Tris acetate, 10 mM Mg acetate, 1 mM dithiothre-
itol, pH 7.9, 25◦C) supplemented with 320 MS-adenosyl-
L-methionine (SAM). As a negative control, DNA was in-
cubated in the same buffer without M.EcoGII. The DNA
samples were then supplemented with ATP (20 M) and
additional SAM (160 M) and then digested with a Type I
enzyme (CC5-1, CC5-2, CC30-1, CC45-1 or the NY TRD
hybrid) for 14 min at 37◦C. As a control, methylated and
unmethylated DNA was digested with EcoRI.
RESULTS AND DISCUSSION
Assigning TRDs to target sequences
Each TRD was given a one letter code (A to Z and a* to
f*), Table 1. There were 14 TRD1 examples and 18 TRD2
examples in our survey and these are found in 17 different
CC or ST groups. Table 1 lists the target specificity and site
of methylation for each TRD in our survey. These data were
obtained by pairing TRDs and determining the complete
target for each TRD pair as described in the next section
and in full in the Supplementary Data. Of interest are the
TRD pairs B and P andU and c*. These pairs recognize the
same DNA sequence namely AGG and GAY respectively.
Amino acid sequence comparisons of B with P and U with
c* are shown in Figure 2.
TRDB and TRDP are virtually identical throughout the
TRD region even though TRD B is the first TRD in the
HsdS subunit and TRD P is the second TRD in the HsdS
subunit, (Figure 2A). While the high level of sequence iden-
tity is expected for Type I systems in the same family, the
high level of identity between TRDs found in the first or
second position in the HsdS subunit is more unusual. How-
ever, such a situation has previously been observed in com-
parisons of the Type I systems in Salmonella blegdam and
E. coli R124 (48).
In contrast, TRDsU and c* are both examples of the sec-
ond TRD in the HsdS subunit recognizing 5′-GAY-3′ but
the level of identity between them is much lower (∼36%)
(Figure 2B). This level of identity between TRDs recogniz-
ing the same target is expected if the TRDs are from differ-
ent Type I RM families so the low level of identity observed
here is unusual. Despite this low level of sequence identity,
the predicted secondary structure elements are the same as
expected from the early work of Sturrock and Dryden (49).
In fact, all of the TRDs in the Sau1 family of RM systems
align well when secondary structure elements are taken into
consideration (50) and they will have the same protein fold
(Supplementary Data: PROMALS alignments). Therefore,
it should in future be possible to predict the precise amino
acid to nucleotide contacts involved in sequence recognition
as was done for the Type IIG TRDs (51,52).
Determination of complete target sequences recognized by
pairs of TRDs
Tables 2, 3 and 4 show the TRD combinations investigated
in this work and those investigated previously by ourselves
and others along with their combined target sequences,
methylation specificity and the methods used to determine
these parameters. The full experimental data are given in
the Supplementary Data. Many of the TRDs were investi-
gated in more than one MTase and in more than one assay
thus our set of data represents a self-consistent set. DNA
cleavage and ATP hydrolysis assays were performed on pu-
rified MTases mixed with purified R subunit while SMRT
data were collected from E. coli genomic DNA isolated af-
ter the hosts were transformed with a plasmid expressing
the MTase or directly from S. aureus genomic DNA. The
adenines targeted for methylation were determined easily
by SMRT sequencing but for systems not examined in this
manner, it was assumed if there was a single adenine in
the site recognized by the TRD that this was the target for
methylation.
Table 2 contains systems from a range of CC in-
vestigated previously as well as several examined in
this study. It is important to note that in our work
those systems containing M.SauMRSII plus S. SauMR-
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Figure 2. Amino acid sequence and secondary structure alignment of two pairs of TRDs recognizing the same DNA target. The TRD sequences are
highlighted in yellow. Consensus secondary structure shows ‘h’ for  helix and ‘e’ for  sheet. (A) TRDs B and P are examples of a first and a second TRD
respectively recognizing 5′-AGG-3′. (B) TRDs U and c* are both examples of second TRDs with the same specificity, 5′-GAY-3′. The long predicted 
helices at the start and the end of the sequences are the conserved helical spacer regions in the HsdS subunits while the sequence between these helices
makes up the TRD.
SII, M.Sau133ORF1794P plus S.Sau133ORF1794P and
M.SauMRSI plus S.SauMRSI are paired with the HsdR
(SauN315ORF189P) from the N315 strain of CC5 in
DNA cleavage and ATPase assays. Those shown in Ta-
bles 3 and 4 are studied as HsdS paired with the HsdM
(M.SauSTORF499P) from strain S0385 of CC398 and the
HsdR (SauN315ORF189P) from the N315 strain of CC5
(if used in DNA cleavage or ATPase assays). Therefore,
these HsdS are not examined in the context of their natu-
ral genome, but since they are all from the Sau1 family of
Type I RM systems and the HsdM and HsdR of these RM
systems are essentially identical in all of the strains, it is rea-
sonable to assume that the target specificities identified are
those that would be recognized in their natural host.
Identifying the complete target recognized by a member
of the Sau1 Type I RM family when both TRDs have un-
Nucleic Acids Research, 2017 7
Table 2. The Sau1 RM systems with published recognition sequences
Strain name and
genome
reference
Clonal
Complex or
Sequence
Type
S subunit name in
REBASE Recognition sequence
TRDs
assigned
Suggested generic
name
Experimental
method
Reference for target specificity
and method
MW2 (53) CC1 S.SauMW2I CCAY-5-TTAA AF CC1-1 g, s, a g (31)
S.SauMW2II CCAY-6-TGT AG CC1-2 (CC8-2) g, s, a a (36)
N315 (54) CC5 S.SauN315II CCAY-6-GTA AH CC5-2 g, s, a s (CC8-1 and CC8-2 in strain
NRS384 are from ref. 35)
S.SauN315I AGG-5-GAT BD CC5-1 (CC8-1) g, s, a
MRSA252 (55) CC30 S.SauMRSII GWAG-5-GAT CD CC30-1 g, s s (35) g, s (this work)
S.SauMRSI GGA-7-TCG JK CC30-2 s s (35) s (this work)
JKD6159 (56) CC93 S.SauJKDIII GAAG-5-TAC or
complement
Not a Sau1
system
CC93-3 s s (35)
S.SauJKDII GGHA-7-TCG b*K CC93-2 s Note the ambiguity in assigning
CC93-1 and CC93-3 is clarified
with strains ED133 and 32320
and from Table 3.
S.SauJKDI CAG-6-TTC Ma* CC93-1 s
ED133 (57) CC133 S.Sau133ORF451P CAG-5-RTGA ME CC133-1 g g (36)
S.Sau133ORF1794P GGA-7-TTRG Jd* CC133-2 s s (this work)
32320 (58) CC133 S.Sau32320ORFAP CAG-5-RTGA ME CC133-1 g g (36)
S0385 (59) CC398 S.SauSTORF499P ACC-5-RTGA NE CC398-1 g, s g (36) s (this work)
Target sites are shown from 5′ to 3′ with the length of the non-specific spacer shown as a number. Underlined A or T indicates the site of adenine methylation on the top or bottom
strands respectively. The experimental methods used are indicated as g= target obtained byDNA cleavage with a purified enzyme, s= target obtained by SMRT sequencing of E.
coli ER2796 genomicDNA, a= target obtained byATPase assaywith a purified enzyme. Full details are given in the SupplementaryData. S.Sau133ORF1794P is characterized in
this work but is included here as it is part of the RM system found in strain ED133. SauMRSI and SauMRSII characterized byMonk et al. and S.SauSTORF499P characterized
by Chen et al. are also further characterized in this work.
Table 3. The ‘artificial’ Sau1 systems containing novel pairings of TRDs
‘Artificial’ Sau1 RM systems.
Recognition sequence TRDs assigned Experimental method Recognition sequence TRDs assigned Experimental method
AGG-5-RTGA BE a ACC-6-TTC Na* s
GGA-6-RTGA JE g, s ACC-6-RTC Nc* s
ACC-6-TGAR NI g ACC-6-TTRG Nd* g, s
ACC-6-TCG NK g GARA-6-RTGA RE s
ACC-6-TAAA NL g CAAG-5-RTGA TE s
ACC-5-CCT NP s CNGA-6-RTGA VE s
ACC-5-RTGT NQ g, s TCTA-6-RTGA XE g, s
ACC-6-TGC NS s GAC-5-RTGA ZE a
ACC-5-RTC NU g, s GAC-6-TGC ZS a
ACC-6-TTYG NW g, s GGHA-6-RTGA b*E s
ACC-6-TAG NY g, s GAG-6-RTGA e*E g, s
Target sites are shown from 5′ to 3′ with the length of the non-specific spacer shown as a number. UnderlinedA or T indicates the site of adeninemethylation
on the top or bottom strands respectively. The experimental methods used are indicated as g = target obtained by DNA cleavage with a purified enzyme,
s = target obtained by SMRT sequencing of E. coli ER2796 genomic DNA, a = target obtained by ATPase assay with a purified enzyme. Full details are
given in the Supplementary Data.
known targets is difficult and ambiguous as either orienta-
tion may be correct. Hence, we combined TRDs with un-
known targets with TRD E or TRD N to make a protein
recognizing a hybrid sequence in which one half of the tar-
get was already known (Table 3). A variety of methods were
used to determine the target associated with each hybrid in-
cluding DNA cleavage and ATP hydrolysis assays when the
hybrid enzyme could be expressed and purified from E. coli
and SMRT sequencing when the expression and purifica-
tion levels were low, for example, the SauJK enzyme corre-
sponding to the second Type I RM enzyme in CC30 did not
express inE. coli despite its expression in S. aureus byMonk
et al. (35). The ambiguity in assignment of targets in CC93
in Monk et al. (35) is resolved because the TRDsM and b*
occur in more than one HsdS in our survey.
TheDNA sequences for further pairs of TRDs found in a
wide range of CC and ST groupswere then inserted after the
hsdM of CC398-1 in our expression vector and examined to
ascertain the spacer sequence in the natural system (Table
4).
Genomic DNA from S. aureus strains NCTC13435 and
LGA251was prepared and examined using SMRT sequenc-
ing as these strains contain two TRD pairs, XY and e*f*
respectively, which we could not express in E. coli. While
SMRT signatures for the other Type I HsdS in these strains
were very clear (Supplementary Data) and in agreement
with our results from E. coli (Table 4) and those of Monk
et al. (35), these TRD pairs still showed no methylation ac-
tivity even in their normal host. Thus, these TRDs pairs are
not active.
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Table 4. The Sau1 RM systems investigated in this project
Strain name and genome
reference
Clonal
Complex or
Sequence Type
S subunit name in
REBASE Recognition sequence TRDs assigned
Suggested
generic name Experimental method
CO1791 (58) CC97 S.SauC01791ORFAP CCAY-6-RTC Ac* CC97-1 s
HO5096 (60) CC22 S.Sau5096I AGG-6-TGAR BI CC22-1 g, s
LGA251 (61) ST425 S.Sau251I GWAG-5-RTGA CE ST425-1 g, s*
S.Sau251ORF16900P GAG-?-RTTC e*f* ST425-2 Not expressed, no
signature with s*.
S.Sau251II GAAG-5-TAC or
complement
Not a Sau1
system
Same as CC93-3 s*
Isolate 3 (19) CC51 S.SauL3ORFAP GGA-6-CCT JP CC51-1 s
Isolate 3067 (19) CC45 S.Sau347I GWAG-6-TAAA CL CC45-1 g
Isolate 3150 (19) CC15 S.SauL315ORFAP CAAC-5-RTGA OE CC15-1 s
SA40 (62) CC59 S.SauSA40ORF370P GGA-6-RTGT JQ CC59-1 a
CN1 (63) CC72 S.SauCN1ORF415P GARA-6-RTGT RQ CC72-1 a
S.SauCN1ORF1757P GGA-7-TGC JS CC72-2 a
MSHR1132 (64) CC75 S.Sau1132ORF3780P CAAG-5-RTC TU CC75-1 g
S.Sau1132ORF16570P CNGA-7-TTYG VW CC75-2 s
NCTC13435
NCBI Biosample identifier:
ST80 S.Sau13435ORF394P TCTA-?-TAG XY ST80-1 Not expressed, no
signature with s or s*.
SAMEA2479566 S.Sau13435ORF1751P GAC-6-TTYG ZW ST80-2 a, s*
S.Sau13435ORF2165P TCTA-6-RTTC Xf* ST80-3 s, s*
32326 (58) CC873 S.Sau32326ORFAP GAG-6-GAT e*D CC873-1 a
Target sites are shown from 5′ to 3′ with the length of the non-specific spacer shown as a number. Underlined A or T indicates the site of adenine methylation on the top or
bottom strands respectively. TRD pair e*f* in strain LGA251 was not cloned in E. coli while TRD pair XY was cloned. However, no target modification was observed using
SMRT on genomic DNA from either E. coli or S. aureus for these TRD pairs. If the genes are translated, their target is inferred from other TRDs in this table although the
spacer length remains undefined. The experimental methods used are indicated as g = target obtained by DNA cleavage with a purified enzyme, s = target obtained by SMRT
sequencing ofE. coliER2796 genomic DNA, s*= target obtained by SMRT sequencing of S. aureus genomic DNA, a= target obtained by ATPase assay with a purified enzyme.
Full details are given in the Supplementary Data.
Analysis of spacer sequence length in S. aureus Type I RM
systems
It is apparent that the number of base pairs separating the
adenines targeted for methylation and the number of base
pairs in the non-specific spacer between the sequences rec-
ognized by the TRDs is not constant, with the former vary-
ing between 7 and 9 bp and the latter varying between 5
and 7 bp. This variation makes it very difficult to predict
a Type I RM recognition sequence if one knows only the
targets recognized by the two TRDs as the length of the
spacer in the target is not recognized in any obvious man-
ner by the TRDs. An example of this is the CC80-1 enzyme
(Table 4) containing TRDs X and Y of known specificity.
Since the enzyme did not methylate DNA in vivo for the
SMRT analysis, the spacer and hence the complete target
for CC80-1 remain unknown until the enzyme is purified
and analyzed biochemically.While it has been observed that
insertions of multiples of four amino acids into the alpha
helical spacers separating the TRDs can increase the length
of the spacer in the target sequence in a predictable manner
(65–67), it is clear from the structure of HsdS subunits (Fig-
ure 1B) that the junction between the TRDs and the alpha
helical spacers in the conserved region is going to be of cru-
cial importance for determining the fine details of the length
of the spacer in the target sequence as was found for some
Type IIB RM enzymes which contain a subunit equivalent
to HsdS (68). Perhaps even single amino acid insertions or
deletions will serve to rotate the TRD with respect to the
rest of the subunit and thereby change the length of the
spacer. Further progress in understanding the correlation
between amino acid sequence and the length of the target
spacer would be greatly aided by an accurate atomic struc-
ture of a Type I enzyme with DNA as the current models
(12,13) lack sufficient resolution to be informative on this
point.
Linking TRDs pairs to further clonal complexes and sequence
types
After determining the recognition sequences for all of the
TRDs in Table 1 by creating artificial hybrids (Table 3) we
also found that some of these TRD combinations do actu-
ally occur in natural systems as given inTable 5 (and Supple-
mentary Data) (69). As sequence databases expand, more
and more of the possible TRD combinations based on the
TRDs in Table 1 will be found. As mentioned above, al-
though the sequences recognized by the TRDs are known,
the length of the non-specific spacer separating them is un-
known so that the complete target cannot be specified ac-
curately without experimentation.
Further TRDs in S. aureus Type I RM systems
Searching the publicly available sequences in the NCBI
database with individual TRD sequences revealed that
some of those given in Table 1 can be found paired up with
further novel TRDs. We have found four new TRDs shown
in Table 6 in S. aureus strains 21343 and KPL1845. Strain
21343 contains ‘NOVEL 1’ paired with TRD K and the
TRD pair NQ described in Table 3. Strain KPL1845 also
contains the TRD pair NQ and two further systems com-
prised of ‘NOVEL 2’ paired with ‘NOVEL 3′ and ‘NOVEL
4’ paired with TRD f*. Undoubtedly further TRDs will be
found as sequencing continues.
Improving transformation of S. aureus by avoiding targets
recognized by the Sau1 Type I RM family
A general method of preparing DNA suitable for trans-
formation of S. aureus which can overcome the RM bar-
rier should be possible. Several DNAMTases belonging to
Type II RM systems have been found which have extremely
short target recognition sites, namely Hin1523, Nma1821
Nucleic Acids Research, 2017 9
Table 5. Further TRD pairs found in sequenced strains of Staphylococcus aureus
TRD pair Example strain
Clonal complex or sequence type
of example strain REBASE name
AD FDAARGOS 159 ST5 S.Sau159ORF12345P
AL K12S0375 ST692 S.Sau375ORFDP
AU Staphylococcus schweitzeri FSA084 S.SauFSA084ORF355P
AW FDA209P ST464 S.Sau209ORF1697P
BG MRSN8611 ST8 S.Sau8611ORF11430P
BH PLAC6019 ST5 S.Sau6019ORF851P
BU SA-083 ST101 S.Sau083ORF9680P
BY Staphylococcus argenteusM260-MSHR S.SarM260ORF2316P
Bf* SA-083 ST101 S.Sau083ORF1720P
JE Tager 104 ST49 S.Sau104ORF1102P
JL W56227 ST45 S.Sau56227ORF970P
JW CIG290 ST45 S.SauCIG290ORF2408P
JW APS211 ST45 S.SauAPS211ORF9230P
MW FSA037 ST1872 S.SauFSA037ORF2487P
NQ KPL1845 ST96 S.Sau1845ORF2596P
Of* USA300-TCH959 ST1159 S.SauTCH959ORF2844P
Rf* Tager 104 ST49 S.Sau104ORF2433P
TY M21126 ST2250 S.Sau21126ORF1065P
XF 21334 ST109, CC9 S.Sau21334ORF1353P
XF RKI4 ST27 S.SauRKI4ORF1905P
XW 103564 ST80-PVL carrier S.Sau103564ORF678P
ZY D139 ST145 S.SauD139ORF2470P
b*W ST20130941 CC15 S.Sau941ORF4310P
e*f* SA-120 ST425 S.Sau120ORF4875P
Every pair of TRD1 with TRD2 in Table 1 was used in a BLASTP sequence search to identify HsdS subunit sequences in publicly accessible databases. Examples of strains
containing these TRD pairs are shown. ST and CC are from the PATRIC database (69) or derived using www.cbs.dtu.dk/services/MLST (73). Some TRD pairs are present in
many strains while others are rare.
Table 6. New TRD pairs associated with pairs shown in Tables 2, 3 and 4
Subspecies 21343 Bioproject accession: PRJNA53699
> S.Sau21343ORF2597P TRD NOVEL 1 + TRD K
MSNTQKKNVPELRFPGFEGEWEEKKLGEVATFAKGKLGAKKDVSQNGVPVILYGELYTKYGAIVSKIFSKTDIPENKLKMAKKNDVLIPSSGETAIDIATASCIYL
NKGVAVGGDINILTPQKQDGRFISLSINGINKNELSKYAQGKTVVHLYNNDIKNLKIAFPSEFEEQVRIGNFFSKLDRQIELEEQKLELLQQQKKGYMQKIFSQELR
FKDENGNDYPKWEEKKIEDIASQVYGGGTPNTKIKEFWNGDIPWIQSSDVKVNDLILQQCNKFISKNSIELSSAKLIPANSIAIVTRVGVGKLCLVEFDYATSQDFL
SLSSLKYDKLYSLYSLLYTMKKISANLQGTSIKGITKKELLDSIIKIPHNLEEQQKIGDLFYKIDKYISFNKCKIEILKSLKQGLLKKMFI
Species KPL1845. Bioproject accession: PRJNA169473
> S.Sau1845ORF1619P TRD NOVEL 2 + NOVEL 3
MTEQINTPELRFPEFKNEWSYDLVSDVVTNKSKKFDPKKEEAKKDIELDSIEQNTGRLLDTYISNDFTSQKNKFNKGNVLYSKLRPYLNKYYYATIDGVCSSEIWV
LNTLNKDVLANKFLYYFIQTNRFSSVTNKSAGSKMPRADWELVKNIRLYKGSIEEQEKIGYFFSKLDRQIELEEKKLELLEQQKKGYMQKIFAQELRFKDENGNDY
PDWVTKKLGDIGKVAMNKRIYKNETTENGEIPFYKIGNFGKNADTFITREKFDEYKEKYPYPNVGDILISASGSIGRTIEYTGEDAYYQDSNIVWLNHNDEVINKY
LKYFYKIVKWSGIEGTTIKRLYNKNILNTKIELPTVEEQYKMANFLSKLDKIIDIQIEKIELLKQRKQGLLQKMFV
> S.Sau1845ORF2199P TRD NOVEL 4 + TRD f*
MSNTQKKNVPELRFPEFEGEWKDVKFVSIFQEVSNKTSDLAKYPLFSLTVEKGITPKTERYKRDFLVKKSDNFKIVEPRDIVYNPMNVTLGAIDLSKYNYDIALSG
YYHVMKIINSFNPDFISNFLKTEKMIIHYKKIATGSLMEKQRVHFSEFKNIIKKFPTNKEQQKIGDFFSKLDRQIELQVQKLELLQQQKKGYMQKIFSQELRFKDE
NGEDYPDWKEKKLGDITEQSMYGIGASATRFDSKNIYIRITDIDEKSRKLNYQNLTTPDELNNKYKLKRNDILFARTGASTGKSYIHKEEKDIYNYYFAGFLIKFE
IDEQNNPLFIYQFTLTSKFNKWVKVMSVRSGQPGINSEEYAKLPLVLPNKLEQQKIAEFLDRFDQQIELEKQKIEILQQQKKGLLQSMFI
The new TRDs of unknown specificity are termed NOVEL 1, NOVEL 2, NOVEL 3 and NOVEL 4. TRD NOVEL 3 is a second TRD while the
others are first TRDs in the HsdS amino acid sequence. Subspecies 21343 and species KPL1845 also contain S.SauNQ (S.Sau21343ORF1169P and
S.Sau1845ORF2596P respectively).
and Hia5 (70) and EcoGII recognizing and methylating
adenine in the targets 5′-A-3′, 5′-AB-3′ or 5′-BA-3′. The
methylation performed by these enzymes should protect any
DNA molecule from the RM enzymes described here (or
indeed any RM barrier relying upon adenine methylation).
Thus, DNA methylated in vitro with these unusual MTases
could be used in subsequent transformation experiments
even when major RM barriers are present.
We used the M.EcoGII adenine MTase (a kind gift from
Iain Murray, New England Biolabs) to modify all adenines
in several plasmids in vitro. The plasmids were from our col-
lection of plasmids used to determine the target sequences
of the S. aureus Type I enzymes and have been previously
described (31). These plasmids were then mixed with var-
ious purified S. aureus Type I restriction enzymes or, as a
control, the EcoRI restriction enzyme. After one hour of
methylation byM.EcoGII, the plasmidswere completely re-
sistant to digestion by EcoRI and by the S. aureus restric-
tion enzymes (Figure 3). Furthermore, the shuttle vector
pCN36 (47) was also protected fromdigestion by these same
enzymes (data not shown). Subsequent experiments using
the methylated pCN36 to transform S. aureuswere unfortu-
nately entirely unsuccessful (J. A. Lindsay, unpublished re-
sults using strainsHO5096 (CC22), JE2 (CC8) andRN4220
(CC8, hsdR−). The reason for the failure of transformation
with the highly-methylated pCN36 when it should be resis-
tant to all Sau1 RM systems is not clear. This result may
imply a further unrecognized barrier to transformation of
S. aureus or some aspect of the physical properties of highly
methylated DNA. Nevertheless, the method using MTases
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Figure 3. General protection from endonuclease activity using M.EcoGII
MTase to methylate all adenines. Plasmid without M.EcoGII treatment is
digested (− lanes) but plasmid withM.EcoGII treatment is protected from
digestion (+ lanes). Panel (A) uses Sau347I (CC45-1, TRDs C and L) re-
striction enzyme against plasmids E2, E5 and E10 described in (31). Panel
(B) uses SauNY (TRDs N and Y) against plasmids E10, E11 and E12 de-
scribed in (31). Panel (C) uses three different enzymes, SauN315I (CC5-1,
TRDs B and D), SauN315II (CC5-2, TRDs A and H) and SauMRSII
(CC30-1, TRDs C and D), against plasmid E10. In each panel EcoRI re-
striction enzyme was used as a control and markers (M) are in kb.
with very short target recognition sequences may be of use
for transformation of other bacterial species.
CONCLUSIONS
In conclusion, we have determined the target recognition
sequences of a considerable number of TRDs and HsdS
specificity subunits of the Type I RM systems in S. au-
reus. This was achieved using a combination of gene syn-
thesis, endonuclease activity, ATP hydrolysis activity and
single molecule real-time genome sequencing. The systems
analyzed cover a large proportion of the known sequence
types and clonal complexes of S. aureus and delineate more
clearly the barrier to HGT within the S. aureus population.
The data obtained here will allow the construction of new
E. coli strains for preparing methylated shuttle vectors (35)
andMTase reagents for in vitromethylation of DNA (40) to
assist transformation of further S. aureus strains. However,
these approaches are time consuming and it is worth not-
ing that the common shuttle vector used for transformation
of S. aureus, pCN36 (47), contains a target site for almost
every TRD pair investigated in this paper. This means that
pCN36 is inevitably a poor vector for transformation of S.
aureus. The construction of new shuttle vectors completely
lacking Sau1 targets via DNA synthesis, coupled with care-
ful analysis of the fragments to be ligated into the vector
so that they also lack targets, may be an effective way for-
ward to improve transformation of S. aureus now that so
many target specificities have been determined. Obviously,
the avoidance of the sequence AN6-9T, although difficult to
achieve without altering protein coding sequences in a vec-
tor, would be a general method to negate the effect of the
Type I RM systems in S. aureus and other prokaryotes.
Lastly, the determination of so many recognition se-
quences of Type I RM systems in different lineages of S.
aureus, in effect a ‘Rosetta Stone’, means that now the pop-
ulation structure of S. aureus can be investigated from an
epigenetic/evolutionary perspective (4) as performed previ-
ously with, for example,Helicobacter pylori (71) and Strep-
tococcus pneumoniae (72).
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Supplementary Data are available at NAR Online.
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